BALTIMORE, MD, January 13, 2025 – A groundbreaking new study in the INFORMS journal Transportation Science reveals the severe and far-reaching consequences of Russia’s full-scale invasion of Ukraine on global food security. The research highlights an urgent need to address disruptions in the transportation of Ukrainian grains, which have caused dramatic price spikes and worsened food insecurity worldwide, particularly in vulnerable regions such as the Middle East and North Africa.
Cutting-edge chips, especially those designed to power emerging AI applications, tend to receive the most attention in the media and generate the most excitement. However, so-called “legacy” chips are just as important — if not more — to our daily lives.
January is National Blood Donor Month and, not coincidentally, a time when donations tend to ebb. Every two seconds, someone in the U.S. needs blood for serious injuries, childbirth, cancer treatments and more, according to the Department of Health and Human Services.
An audio journey of how data and analytics save lives, save money and solve problems.
Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578
Explore our resources for multiple topics including:
At the start of the school year, Cornell University implemented a strategy of regular testing and robust contact tracing on campus. The plan was expensive, but it’s prevented any major COVID-19 outbreaks at the New York institution.
Overcrowding in emergency rooms is a costly and concerning global problem, compromising patient care quality and experience. In a new study, a researcher from The University of Texas at Dallas investigated whether telemedicine could enhance ER care delivery. "This longstanding problem is mainly driven by the imbalance between increasing patient flow and the shortage of emergency room capacity," said Dr. Shujing Sun, assistant professor of information systems in the Naveen Jindal School of Management and lead author of the study.
When one or more coronavirus vaccines receives FDA emergency use authorization, it will launch a public health and logistics initiative unlike any in U.S. history. Hundreds of millions of doses will have to distributed nationwide and kept cold until healthcare professionals can administer not one, but two doses to each person. And enough skeptical members of the population will have to be persuaded to receive the vaccine to slow virus transmission.
The multiple announcements of potential vaccine candidates in the fight against COVID-19 has been greeted positively around the world, but rolling out immunization to every Canadian who needs and wants it will be a bigger challenge than many campaigns of the past. And it all starts with having to keep things cold as ice — and then some — for far longer than with vaccines such as the flu shot.
The mRNA-based coronavirus vaccine developed by Moderna and vetted in clinical trials at the Detroit-based Henry Ford Health System is based on the same technology used by Pfizer to develop its vaccine candidate, but would not have the same requirement for storage at ultra-cold temperatures. Pfizer and Moderna are the first companies to release partial results from Phase 3 clinical trials in the race to develop a vaccine against the deadly SARS-CoV-3 virus that causes COVID-19.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine